Search Within

Michael J Zelefsky

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (8)
  3. Review (2)
  4. Book Section (1)
Groups
  1. Molecular Imaging and Therapy Service (31)
  2. Survivorship Research (31)
  3. Radiology, Department of (23)
  4. Sloan Kettering Institute Postdocs (16)
  5. Radiation Oncology, Department of (15)
  6. Molecular Pharmacology and Chemistry Program Faculty (13)

More Groups

People
  1. Hebert Vargas Alvarez (17)
  2. Hedvig Hricak (8)
  3. Heiko Schoder (7)
  4. James Eastham (6)
  5. Joseph Osborne (6)
  6. Marisa Kollmeier (6)

More People

Years
  1. 2023 (4)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (2)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (8)
  2. Journal of Nuclear Medicine (3)
  3. Radiology (2)
  4. Urologic Oncology: Seminars and Original Investigations (2)
  5. Urology (2)
  6. American Journal of Roentgenology (1)

More Publications

Publishers
  1. Elsevier Inc. (11)
  2. Elsevier Science, Inc. (5)
  3. Society of Nuclear Medicine (3)
  4. Springer (3)
  5. John Wiley & Sons (2)
  6. Radiological Society of North America, Inc. (2)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Meeting Abstract

    Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation
    Journal Article

    Imber, B. S.; O'Dwyer, E.; Lobaugh, S.; McBride, S. M.; Hopkins, M.; Kollmeier, M.; Gorovets, D.; Brennan, V.; Pike, L. R. G.; Gewanter, R.; more...
    Urology (2022)

    Fulltext@MSK | Save
  • Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer
    Journal Article

    Chesnut, G. T.; Tin, A. L.; Sivaraman, A.; Takeda, T.; Lee, T.; Fainberg, J.; Benfante, N.; Sjoberg, D. D.; Vargas, H. A.; Fine, S. W.; more...
    Urologic Oncology: Seminars and Original Investigations (2021)

    Fulltext@MSK | Save
  • Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer
    Journal Article

    Zelefsky, M. J.; Yamada, Y.; Greco, C.; Lis, E.; Schöder, H.; Lobaugh, S.; Zhang, Z.; Braunstein, S.; Bilsky, M. H.; Powell, S. N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Oncologic outcomes after localized prostate cancer treatment: Associations with pretreatment prostate magnetic resonance imaging findings
    Journal Article

    Wibmer, A. G.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Nincevic, J.; Nikolovski, I.; Sala, E.; Gonen, M.; Carlsson, S. V.; Fine, S. W.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • (11)C-choline PET/CT in recurrent prostate cancer: Retrospective analysis in a large U.S. patient series
    Journal Article

    Michaud, L.; Touijer, K. A.; Mauguen, A.; Zelefsky, M. J.; Morris, M. J.; Lyashschenko, S. K.; Durack, J. C.; Humm, J. L.; Weber, W. A.; Schöder, H.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Prognostic value of pretreatment MRI in patients with prostate cancer treated with radiation therapy: A systematic review and meta-analysis
    Review

    Woo, S.; Han, S.; Kim, T. H.; Suh, C. H.; Westphalen, A. C.; Hricak, H.; Zelefsky, M. J.; Vargas, H. A.
    American Journal of Roentgenology (2020)

    Fulltext@MSK | Save